Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.
Press releases published on September 5, 2025
September 5, 2025
Cycle Clarity to Showcase AI Ultrasound Standardization Platform at ASRM 2025 in San Antonio
Indeterminate
EIN Presswire
September 5, 2025
MD Anderson and Phoenix SENOLYTIX announce cross-licensing agreement of CaspaCIDe™ for cell and gene therapies
Indeterminate
EIN Presswire
September 5, 2025
Video Plus Print Launches Global Campaign Showcasing the Impact of Video-in-Print on Modern Marketing and Branding
Indeterminate
EIN Presswire
September 5, 2025
Back-to-Campus Shipping Services: Custom Crating for Research Labs and Academic Departments
Indeterminate
EIN Presswire
September 5, 2025
Revive Therapeutics Announces Extension of Proposed Private Placement
Indeterminate
GlobeNewswire
September 5, 2025
Helios Alliance Announces National Opioid Conference Featuring Former White House Drug Policy Director Dr. Rahul Gupta
Indeterminate
GlobeNewswire
September 5, 2025
DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq
Indeterminate
GlobeNewswire
September 5, 2025
DBV Technologies met en place un Programme At-The-Market (ATM) sur le Nasdaq
Indeterminate
GlobeNewswire
September 5, 2025
Publication relating to transparency notifications
Indeterminate
GlobeNewswire
September 5, 2025
Publication relative à des notifications de transparence
Indeterminate
GlobeNewswire
September 5, 2025
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
September 5, 2025
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
September 5, 2025
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
September 5, 2025
Artelo Biosciences Announces Closing of $3.0 Million Public Offering
Indeterminate
GlobeNewswire
September 5, 2025
Gyre Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Indeterminate
GlobeNewswire
September 5, 2025
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
September 5, 2025
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
September 5, 2025
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
September 5, 2025
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire